Category Archives: Medicine

Holistic Drug Rehab Effective For Combatting Increased Benzodiazepine Abuse

The Substance Abuse Mental Health Services Administration (SAMHSA) recently published a study that indicates benzodiazepine usage has tripled over the past decade.

Benzodiazepines are a class of drugs which are used to treat seizures, anxiety and insomnia. They were created back in the 1950’s as an alternative to barbiturate use within the mental health field. While opiates still remained the number one abused controlled substance in this study, benzodiazepines ranked number two.

“All FDA approved medications have their place when used properly,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “The issue is when those substances fall into the wrong hands. And, since there are more individuals being prescribed these types of drugs, the chances of abuse by a friend or relative are increased. Fortunately, holistic drug rehab is effective in overcoming these types of addictions. Mountainside’s entire team of professional social workers and counselors all have extensive experience in the field of addiction. Our drug rehab program is second to none.”

If you know or suspect that your friend or loved one is abusing benzodiazepines, or any other type of substance, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers, as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Waters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

Via EPR Network
More Healthcare press releases

Bath Salt Abuse Becoming International Problem

The most recent substance abused and labeled a designer drug is fast becoming an international epidemic.

Bath salts, a potentially deadly combination of various chemicals such as mephedrone and MDPV, are highly addictive and extremely dangerous, producing hallucinations and physical manifestations that can be fatal.

“What’s remarkable about this substance is that, on the package, it is actually labeled ‘not for human consumption’,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “It’s terrifying to think that experimentation happens with substances that aren’t even to be ingested into the human body. And, unfortunately America is not the only country to be grossly affected by this epidemic. Countries such as England are also experiencing marked increase in the improper use of bath salts as well as the detrimental effects that follow bath salt abuse.”

Bath salts are particularly appealing to teens and young adults for a variety of reasons, mainly because they are easy and inexpensive to obtain. Producing side effects such as hallucinations and heart palpitations, the effects of the improper use of bath salts have been cited as the cause of death in several autopsies performed globally.

If you know or suspect that your teen or young adult is abusing bath salts or any other type of substance, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

Via EPR Network
More Healthcare press releases

A Dream Team for HIV Cure Research

This Sunday will mark the 30th anniversary of the first reports of AIDS in the United States. There is still a long road ahead toward eradicating HIV, but a “dream team for HIV reservoirs cure” has been created since 2003 with this objective.

While the HIV pandemic is still growing, with more than 7,100 daily new cases of infection, there is evidence that antiretroviral therapy costs could treble over the next 20 years.

Today there are more than 30 drugs approved to treat HIV, and while they cannot cure it, they can keep the virus suppressed to undetectable levels in blood. But HIV persists dormant in some “reservoir” and each time antiretroviral therapy is stopped, the infection rekindles. Lifelong therapy is therefore mandatory but brings problems of compliance, resistance, toxicity and cost.

These reservoirs were first described in 1997 and 5 years later Alain Lafeuillade, a French Doctor involved in HIV research, considered that it would be the challenge of the 21st Century. He consequently founded a working group uniting researchers from all over the world that first met in December 2003. This first “HIV Reservoirs, Persistence and Eradication Strategies Workshop” welcomed around 130 scientists actively involved in the field. “At that time we were seen as utopists, Doctor Lafeuillade said, and quite ignored by funding agencies and pharmaceutical companies”.

But minds greatly changed in the following years and in 2009, when the “dream team” met for the 4th time, the workshop was officially supported by the NIH (National Institutes of Health) and the ANRS (French Agency for AIDS Research). In between 2 workshops, the group of scientists are in touch via a specialized website portal they also have created.

“At the end of this year we will reconvene, Doctor Lafeuillade added, and be more than 200 scientists working on HIV cure”. The program of this 5th workshop goes from in vitro models of HIV persistence to HIV eradication clinical trials. “Participants will be able to define a clear road map for HIV cure research with a precise agenda”, Doctor Lafeuillade emphasized.

Via EPR Network
More Healthcare press releases

Bath Salts Pose Legitimate Danger For Teens, Young Adults

It may be difficult to believe that something with such an innocuous name can be so dangerous, even deadly.

A new designer drug marketed as “bath salts” has nothing to do with a relaxing time bathing. In fact, many are using the product with no thought of relaxing at all.

“Bath salts are being legally sold and are being used by more and more young people to get high,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “They can be found at many convenience stores or smoke shops, and they contain stimulants such as mephedrone and MDPV. Individuals generally snort them to get high, but they can also be smoked or injected. Some states have banned the sale of bath salts and Mountainside is hoping to help push a nationwide ban on the substance. If we don’t address this problem immediately, there will be a whole new drug epidemic plaguing America and, with that, comes tragic deaths.”

Bath salts are among the growing group of the so-called designer drugs that produce a high similar to that of a methamphetamine or cocaine, but with the addition of hallucinogenic side effects. Sold under a variety of different names, the use of bath salts has been linked to suicide, hallucinogenic rages, and even speculation of murder.

If you know or suspect that your teen or young adult is abusing bath salts or any other type of substance, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

Via EPR Network
More Healthcare press releases

Life Line Screening Reveals Private Health Screening Survey

Life Line Screening has published the results of its private health screening survey.

Private health screening is becoming increasingly popular in the UK & Ireland. Whilst there are metrics on the benefits of screenings in detecting potentially life-threatening conditions early, and thereby preventing conditions such as Stroke and cardiovascular disease, Life Line Screening’s report aims to provide more evidence relating to the effects of screenings on modifying behavioural change.

One area of debate about health screening is that certain types of health screening can lead to “false reassurance”. An individual who has a screening may gain the impression that they have a clean bill of health if no risk factors have been identified. As a result, they may choose to pay less attention to their health overall and lead a less healthy lifestyle than they would otherwise have done. This research aims to look further at this hypothesis and gauge a better understanding of the motivations of individuals who have health screenings, based on evidence rather than subjective judgements. It aims to understand the proportions of individuals who choose to improve their health as well as the number of people who choose not to.

136 people who had Life Line Screening health screenings were surveyed in July 2010 by a researcher from Addenbrookes Hospital. They were invited to answers questions based on their perceptions on health and lifestyle changes as a result of having had a screening.

When asked “Did going for a screening make you think more about your health?” 77% of responders answered yes. Participants were then asked if they have made any positive changes to their lifestyle following their screening. 51% stated they had started eating more healthily, 45% stated they had started exercising more than before (and 18% of the total had tried a new exercise), 35% reported losing weight, 71% had focused on keeping weight at a healthy level, 60% were careful about alcohol consumption, 52% commented that they were controlling their stress levels, 30% reported they had read more health-focussed publications and 74% paid more attention to their overall health.

Only 7% of all responders commented that they had led less-healthy lifestyle following their screening.

The full report on the impact of health screening on lifestyle change is available on the Life Line Screening website in PDF format.

Via EPR Network
More Healthcare press releases

Innovators in Health Care Meeting at HealthCamp Florida on July 30, 2011

The inaugural meeting of HealthCamp Florida will be held in Tampa, Florida on July 30, 2011. It will be held on Saturday, July 30 at Kforce in Tampa (1001 E. Palm Ave., Tampa, FL 33605). This is the inaugural event for HealthCamp Florida and the theme is ‘The remarkable innovations that are transforming healthcare.’ The focus will be on technology, policy and process areas and it is expected that these three areas will help to cross-pollinate thoughts, speakers and attendees and inform the discussions.

HealthCamps have been held in a number of other cities, including Boston, Philadelphia, San Francisco and other locations. HealthCamp will be similar to a BarCamp type of unconference but the attendees and speakers will represent a wide variety of people, industries and advocates focused around health care topics. These events have become popular because they involve interesting, high-energy people talking about interesting things.

One of the goals of HealthCamp Florida is to raise awareness of the remarkable innovators and innovations available right here in Florida. The event will bring together interesting people who might otherwise not meet at their own individual industry meetings. This will allow them to share, collaborate, learn and inspire. Some of the extraordinary innovators who are on the cutting edge of health care innovation have committed to attending the event and speaking. They will cover topics ranging from a new non-invasive medical device that provides more accurate predictions of heart risk, to iPhone and iPad apps for health care, to a neural communications device to help the brain communicate with prosthetic limbs, and to a new way to manage patient data and more. The website is www.healthcampflorida.org.

About HealthCamp Florida: HealthCamp Florida is part of the HealthCamp group of events and is designed to look at innovations in HealthCare in general and, focus on people, companies and innovations in Florida.

Via EPR Network
More Healthcare press releases

New Online Resource for Insulin Dependent Diabetics

Insulin dependent diabetics now have a new online resource designed specifically for them. The resource, the LongActingInsulin.com blog, scours the web for news and views of interest to both type 1 and type 2 diabetics to provide them with a “one stop-shop” for advice, entertainment and information.

“People are busy,” says the new blog’s editor, Lynn Woods, “They don’t have time to surf the web after work to see what’s interesting or important in the world of diabetes research, so we do it for them. Some of our blog posts are entertaining, most are educational, and many contain valuable up-to-the-minute information on diabetes.”

Woods describes the new blog, which launched in January and focuses on users of long acting insulin, as “informal”. “We try to approach diabetes from a positive perspective. We believe that people can not only cope with diabetes, they can thrive with it.”

A quick look through the blog showcases its diversity: an article about diabetes-sniffing dogs that warn their owners when their blood sugar gets low, FAQs about insulin pumps, tips on giving insulin injections to your cat, a diabetic-friendly lemon cheesecake recipe, stories about celebrities with diabetes, a prescription coupon offering $10 savings on Lantus SoloSTAR long acting insulin, and a wealth of current information on diabetes research and diabetes medication.

Unexpectedly, the article Kudzu Used as Diabetes Medication in Chinese Medicine has attracted the most readers by far, says Woods. Other popular diabetes blog articles involve recent developments in non-invasive blood glucose monitors and super-long-acting insulin, and advice on giving insulin injections to cats.

Diabetes affects almost 26 million Americans, over 8% of the population. Of those 26 million, an estimated 7 million remain undiagnosed. Diabetes is an incurable and progressive disease with serious complications, and is the seventh leading cause of death in the United States.

Via EPR Network
More Healthcare press releases

Bath Salts Abuse Tops Newest Designer Drug Trend

The use of bath salts among teens and young adults is fast becoming the drug of choice to obtain a “legal high” because of their relative low cost as well as their ease of acquisition.

“Designer drugs are simply legal substances that have been modified to produce a high,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “The concept of designer drugs isn’t new; in fact, it has been around for decades. Individuals discovered that they could obtain a high from ordinary chemicals such as paint thinners, glue and aerosol cans. The effects of the substances being manipulated are becoming increasingly dangerous compared to their predecessors. And, the abuse is growing at an alarming rate. Unless lawmakers enact laws banning bath salts, we’re going to have a new type of drug epidemic on our hands.”

Bath salts are commonly smoked, snorted and injected. Their effects have been compared to a hallucinogenic cocaine, with users experiencing much of the same devastating and dangerous side effects such as convulsions, high blood pressure, heart attacks and even death.

If you know or suspect that your teen or young adult is abusing bath salts or any other type of substance, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Waters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

Via EPR Network
More Healthcare press releases

Medelita Professional Organization Embroidery Logo List Continues to Grow Weekly

Medelita ®, breakthrough performance maker in lab coats and medical scrubs for both men and women, is honored to have a continuously growing list of logo requests received from a variety of professional organizations as well as existing customers.

Logos embroidered on lab coats and medical tops demonstrate pride and accomplishment to colleagues and patients alike. Medelita often refers to embroidery as, “the closest thing to wearing a diploma”. It is because of this significance of wearing both name & title embroidery and the respective logo of a medical or dental specialty, that Medelita has made a commitment to provide the finest quality and craftsmanship as evidenced in every stitch that goes onto a Medelita garment.

Medelita continues to focus on their customer base. As per request by existing customers, the company has added several professional logos to their existing list which include: the American Academy of Cosmetic Surgery (AACS), the American Academy of Dermatology (AAD), the American Association of Endodontists (AAE), the American College of Emergency Physicians (ACEP), the American College of Mohs Surgery (ACMS), the American Academy of Physician Assistants (AAPA), the American College of Physicians (ACP), the American Society of Plastic Surgeons (ASPS), Dental Caduceus, Veterinary Caduceus, American Medical Women’s Association (AMWA), the American Society for Aesthetic Plastic Surgery (ASAPS), the International Society of Aesthetic Plastic Surgery (ISAPS), the society of Dermatology Physician Assistants (SDPA), and Texas Nurse Practitioners (TNP).

Many of the above professional organizations contacted Medelita directly to submit their logos. The organizations recognize a synergy with the quality and professional image that Medelita put forth, and thus selected the company as their preferred vendor for lab coats and scrubs. Medelita is honored to provide such services as well to offer a vast number of professional organization embroidery options.

Via EPR Network
More Healthcare press releases

Medelita Offers a Professional Organization Logo Embroidery Option for Customers

Medelita®, a performance lab coat manufacturer for both men and women, is pleased to provide customers with the option of adding an embroidered Professional Organization Logo when purchasing lab coats and medical scrubs.

Medelita, a leader in online scrubs and lab coats, is honored to have affiliations with numerous professional organizations within the medical and dental industries, including the American Medical Women’s Association and the American Academy of Physician Assistants. Receiving approval to embroider such prestigious logos is indicative of the exceptional quality in craftsmanship and tremendous attention to detail, by Medelita.

Medelita founder, Lara Manchik, PA-C says, “We spend a tremendous amount of time and energy ensuring that every single inch of fabric, trim and finishing detail is perfect. But truly, when a new customer receives their first Medelita lab coat (or clinician scrubs), the very first thing they see is the embroidery. It is their mark of achievement, their symbol of dedication and professionalism that must be displayed with the utmost quality and attention to detail. That is our commitment to our customers and colleagues. We are excited to provide this additional service to our prestigious customer base.”

The embroidered logos are digitized in-house by the expert embroidery team at Medelita, and are stitched directly to the medical uniforms rather than being applied as a typical patch logo. For both custom logos and Professional Organization logos, Medelita embroidery exudes the very highest level of quality and professionalism while making a bold statement to patients and colleagues alike. Medelita often refers to their embroidery services as “the icing on the cake”, allowing medical professionals to display their titles and affiliations with pride and sophistication.

Via EPR Network
More Healthcare press releases

New Report on Fighting Chronic Disease Examines the Importance of Non-Communicable Diseases in Global Health Care

In the first of a series of new reports, a coalition of pharmaceutical industry trade organizations outlines the serious burden that chronic diseases place on patients and global health care systems.“Fighting Chronic Disease: Importance of Non-communicable Diseases” is the first of four reports that look at this growing issue for patients and health care systems around the world.

The report was compiled by the European Federation of the Pharmaceutical Industries and Associations, the International Federation of Pharmaceutical Manufacturers & Associations, the Japan Pharmaceutical Manufacturers Association, and the Pharmaceutical Researchers and Manufacturers Association. Together, these organizations highlight the powerful role that public-private partnerships can play in mitigating the burden of chronic disease. Non-communicable diseases like stroke, heart disease, diabetes, and cancers can often strain global health care resources, and targeting the main risk factors of these conditions can significantly reduce the burden of these diseases worldwide.

Most NCDs are preventable because they are caused by modifiable risk factors, which include poor diet, lack of physical activity and tobacco use. Every year, more than 5 million people die because of direct tobacco use and 2.8 million die from being overweight or obese. High cholesterol accounts for 2.6 million deaths and 7.5 million die because of elevated blood pressure. Individually, chronic disease lowers quality of life for those affected, causes premature deaths and negatively impacts the economic solvency of families, communities and nations. Interventions that focus on better diet, increased physical activity and access to vaccines have been proven to decrease the incidence of chronic disease and improve quality of life.

The pharmaceutical industry has long recognized the economic and social burden of non-communicable diseases (NCDs) and has been working with governments, health care providers, patients groups and other stakeholders as an active solution partner in lessening this burden. The industry promotes and supports health prevention and promotion strategies and patient-centered approaches to managing chronic conditions and their risk factors. At the same time the global biopharmaceutical industry leads the search for new cures and the research and development of new medicines to treat or prevent non-communicable diseases. There are currently thousands of medicines either in clinical trials or awaiting approval to treat NCDs. The great challenge in preventing and controlling NCDs on a global scale is finding patient-centered solutions that reduce the burden on global health care services by promoting individual healthy lifestyles.

The R&D-based pharmaceutical industry works to improve the health and quality of life of all patients, and is committed to continuing partnerships that tackle these complex issues including extensive investment in R&D programs dedicated to the development of new NCD preventative and treatment products. Both prevention and treatment play an important role in addressing the problem of non-communicable diseases.

The full report is available at
http://globalhealthprogress.org/mediacenter/index.php/new-report-examines…

Via EPR Network
More Healthcare press releases

Will the Catholic Church & the U.S. Courts Embrace Advanced Cell Technologies “Embryo-Safe” Technique Using Embryonic Stem Cells?

Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.
• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Via EPR Network
More Healthcare press releases

Global Health Progress Releases Non-Communicable Diseases Partnerships and Programs List

Global Health Progress compiled a list of non-communicable disease treatment programs from around the world, highlighting partnerships to address cancer treatment, diabetes care, epilepsy programs and more. The programs, sponsored by leading companies like Astra Zeneca, Abbott, Novo Nordisk, and Bayer Healthcare, aim to increase awareness of non-communicable diseases in the developing world.

“Our goal in creating this list is to bring awareness to these companies who work so hard at fighting diseases in developing countries,” explains Mark Grayson, Vice President of Communications and Public Affairs at PhRMA and key developer in the Global Health Progress initiative. “Non-communicable diseases are the leading killer in many of these countries, and without the help of these programs they would continue to increase.”

Global Health Progress works with partner groups to encourage and sustain funding for the research and development of healthcare in developing nations. Improving health care systems and access to medicines, especially in the developing world, requires multifaceted approaches and solutions. Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people in developing countries.

Read the full list of non-communicable disease treatment programs here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/NCD-Health-Partnerships-and-Programs_Worldwide-05-02-11.pdf.

Via EPR Network
More Healthcare press releases

Side by side comparison of Advanced Cell Technology & Geron Corporation

Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements: http://www.sec.gov/Archives/edgar/data/11...

Via EPR Network
More Healthcare press releases

Underage Drinking Continues To Plague America

It’s no secret that many of America’s youth are looking for the quickest fix or high. Often times, they turn to a readily available substance found in many Americans’ homes: alcohol.

Statistics show that by age 18, 70% of teens have had one drink. While it’s true that, when teens do drink, they drink less often than adults; however, when drinking they tend to drink more than adults: approximately 5 drinks on a single occasion.

In addition, research indicates that 40% of adults who started drinking before age 15 say that they have the signs of alcohol dependence, four times higher than for adults who delayed drinking until after 21 years old.

“Underage drinking is a continuing and growing problem in America and is one that is hard fought on many fronts,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “Programs such as DARE and other school-based education programs go a long way in getting the message out about the dangers of underage drinking. With continued effort, we believe that we can decrease the underage drinking statistics and give renewed hope for the future of America.”

Underage drinking is a major contributor to deaths among those under 21 years old. 5,000 people under 21 die as a result of underage drinking annually – approximately 2,000 from motor vehicle crashes, 1,600 from homicides, 300 from suicides and hundreds more from other injuries.

If you know or suspect that your teen or minor has a problem with alcohol, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

The compassionate, caring treatment team at Mountainside is comprised of licensed and certified counselors and social workers as well as a Nurse Practitioner and a Registered Nurse, both of whom have specialization and extensive experience in drug addiction and alcohol treatment. For clients who may have psychiatric issues and/or a dual diagnosis, Mountainside provides the services of a Psychiatrist who also has specialization in addictions. As a result of their unique, innovative approaches to addiction treatment over the past 13 years, Mountainside has become the model for the addiction treatment field.

Via EPR Network
More Healthcare press releases

From Universal HIV Testing to HIV Cure

People involved in the fight against HIV/AIDS will gather in Marseille, France, May 23-25, 2012 for an international AIDS Conference under the theme: ‘From Universal HIV Testing to HIV Cure’.

The ISHEID (International Symposium on HIV & Emerging Infectious Diseases) is a major scientific event attracting doctors, biologists, researchers, patients’ representatives and policy makers from all around the world. Its next edition, to be held just more than one year ahead, will focus on recent developments against this pandemic.

Despite major advances in antiretroviral therapy, HIV still infects daily 2,000 new individuals and kills 2 millions each year. Current treatments are life-long with problems of compliance, resistance, toxicity, access, and cost.

‘There are advances both in the area of prevention, testing and potential cure’ told Alain Lafeuillade, a French Doctor involved in the organization of the conference. ‘Our driving force is to draw to the conference the best experts in the world for each program theme’. Antiretroviral treatment as prevention (or pre-exposure prophylaxis) will be debated with the pros and cons. Human rights and access to HIV care will be the focus of en entire session. Current issues in antiretroviral therapy management will be discussed during 2 sessions. Finally, the best American experts in the field of HIV reservoirs and eradication research will present their latest discoveries in the search for a cure.

The international Steering Committee will actively build a program the most exciting possible in the forthcoming months. Meanwhile, interviews of renowned experts are regularly published on the meeting website: http://www.isheid.com/en/committees/interview.html

Via EPR Network
More Healthcare press releases

New Website Dedicated To Stem Cell Investors

Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Regenerative medicine and Stem Cell research:

Utter those words at your next dinner party or casual gathering of friends and family. You will receive a concoction of half-truth’s and out right fallacy responses. Stem Cell research conjures images of futuristic Star–Trek like preservation chambers, human looking ears protruding oddly from the backs of mice, or worse yet an image of a late term fetus. Nothing could be farther from the truth when entering the reality of Regenerative medicine.

Never before has this area of research been more exciting and promising than right now. There is a medical revolution brewing, and like any revolution, there are those who want to suppress this uprising for continued personal and ideological gains. If we were to take all the major advances in the past 500 years of human medical history and multiply its effect by 10 fold it still would not compare to the paradigm shift in health care delivery that the world may witness in this decade using stem cells. Imagine that an $800,000 heart transplant is no longer needed and that instead the same money spent on one patient can now be stretched out to treat 20 patients who are needing a heart transplant. Is this what Regenerative medicine has in the offing? Only time will tell. Our healthcare system could very well be on the verge of a quantum leap moment thanks to regenerative medicine.

The Food and Drug Administration (FDA) authorized 3 trials using human embryonic stem cells (hESC) in late 2010. Validation of hESC research efforts and the culmination of billions spent on research are coming to fruition. FDA validation for the treatments of spinal cord injury and age related macular degeneration is expected in 2011. It may be the shot heard around the world event sometime in late Q-4 2011 for the Regenerative medicine sector.

Via EPR Network
More Healthcare press releases

Medelita medical coats feature state of the art fabrics and durable design features

Medelita®, maker of breakthrough performance medical coats for both men and women, offers the best selection for those medical professionals who are looking for functional, professional appearing coats. Featuring state of the art materials and smart, flattering designs, Medelita continues to push above and beyond the competition in order to offer medical professionals the very best quality and selection in the medical uniform market.

Medelita medical coats are made from pre-shrunk, 100% cotton textured fabric, which allow for a soft, sophisticated finish that is immediately noticeable. While most medical coats are unisex in styling, Medelita coats are contoured gender specifically for men and women, creating a durable and functional fitting garment that remains comfortable throughout the work day. The overall dimensions and styling of the medical coats are specifically designed to allow for ample forward reach without limiting range of motion in the arms, shoulders, or neck. In addition, Medelita coats also offer modern features like women’s rounded lapels and men’s blazer chest pockets.

As medical professionals wear medical coats in high pressure, stressful situations, Medelita medical coats use breathable 100% cotton fabric that features High-IQ Easy Care Plus wrinkle resistance and Advanced Dual Action Teflon fabric stain protector, the latter of which allows fluids to simply run right off the fabric.

Via EPR Network
More Healthcare press releases

President Obama Administration Intervenes To Curb Prescription Drug Abuse

In response to America’s growing prescription drug abuse problem, the Obama administration has taken measures to help curtail prescription drug abuse by enacting new FDA legislation.

The new FDA legislation is a two-fold approach requiring participation from both drug makers as well as physicians who prescribe opiates. Drug makers will be required to provide physicians with materials for patients which explain the risks and benefits of opioid use. In turn, physicians will be required to understand how to correctly prescribe opiates as well as provide counseling to patients on the correct use of opiate pain medications.

“This is a positive step towards helping curtail America ‘s growing prescription drug epidemic,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “It’s important that physicians have proper training in prescribing opiates and, additionally, it’s crucial that a patient understands the risks of taking opiates. Thankfully, the government understands and acknowledges that this problem is plaguing America. With these concerted efforts, in the future we should be able to see a decline in prescription drug abuse.”

Statistics show that in 17 different states, unintentional drug overdose is the leading cause of injury among its citizens. In addition to the new FDA regulations, President Obama has asked for an additional $123 million for drug prevention programs as well as an addition $99 million for treatment programs for fiscal year 2012.

If you know or suspect that your loved one has a problem with prescription narcotic abuse, Mountainside Drug Rehab and Alcohol Treatment Center offers professional intervention services to assist you in getting them the help that they need to recover. For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober.

Via EPR Network
More Healthcare press releases

Medelita partners with the Society for Dermatology Physician Assistants

Medelita®, maker of breakthrough performance lab coats for both men and women, announces a new partnership with the Society of Dermatology Physician Assistants. Member benefit discount and affiliation agreement begin on May 1st.

The Society of Dermatology Physician Assistants is a non-profit professional organization comprised of individuals who provide dermatologic care, or have expressed interest in the field of dermatology. The SDPA organization, founded in 1994, has over 1,700 members and continues to grow. The main focus of the organization is to provide continuing medical education to its members, form leadership structure, act as an advocate for members, and develop resources for the evaluation and hiring of Physician Assistants. Medelita is proud to have this affiliation with such a prestigious PA organization, as the founder is also a PA. The partnership is extremely complimentary.

Dermatology PAs find Medelita lab coats to be especially professional and classy, with a comfortable, ergonomic fit. With a fit similar to professional clothing, and styling and workmanship improvements throughout, doing procedures from multiple angles and positions is now easier and more comfortable. Coupled with the Advanced Dual Action Teflon® fabric protector, the performance of the lab coats is ideal for those clinicians who are at higher risk for exposure to bodily fluids or other spills. Medelita high-performance lab coats help to ensure a clean, bright white appearance by preventing soil and stains from setting in, and also allowing a fluid barrier.  They wash better than any other lab coat available, and stay bright white.

“We recently received a testimonial from a dermatology PA who said that on the very first day that she received her Medelita lab coat, blood splashed onto the sleeve during a procedure,” shares Lara Manchik, PA-C and founder. “She simply “brushed” it off with a hand towel – with no trace of it left on the surface.  Her supervising MD immediately asked where he could get a similar coat of the same performance quality.”

Via EPR Network
More Healthcare press releases